Tempus AI (NASDAQ:TEM) Sets New 1-Year High at $46.25

Tempus AI, Inc. (NASDAQ:TEM) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $46.25 and last traded at $45.70, with a volume of 145096 shares changing hands. The stock had previously closed at $43.87.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on TEM. JPMorgan Chase & Co. began coverage on Tempus AI in a report on Tuesday, July 9th. They set an “overweight” rating and a $42.00 price objective for the company. Bank of America assumed coverage on Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $41.00 price target for the company. William Blair assumed coverage on Tempus AI in a report on Tuesday, July 9th. They issued an “outperform” rating for the company. Needham & Company LLC assumed coverage on Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $47.00 price target for the company. Finally, Loop Capital assumed coverage on Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 price target for the company. Nine analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $45.63.

Tempus AI Stock Up 0.8 %

Hedge Funds Weigh In On Tempus AI

Institutional investors have recently modified their holdings of the stock. Northwestern University acquired a new position in shares of Tempus AI during the 2nd quarter worth about $491,000. ARK Investment Management LLC acquired a new position in shares of Tempus AI in the 2nd quarter valued at approximately $18,294,000. Finally, EFG Asset Management North America Corp. acquired a new position in shares of Tempus AI in the 2nd quarter valued at approximately $1,333,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.